Mirza Ismail Baig: Silent but Significant – The Clinical Importance of Pulmonary Embolism
Mirza Ismail Baig, Clinical Intern and Physician Assistant at CARE Hospitals, Quality CARE India Limited, shared a post on LinkedIn:
“Silent but Significant: The Clinical Importance of Pulmonary Embolism
Pulmonary embolism (PE) remains one of the most potentially fatal yet frequently underrecognized cardiovascular emergencies.
The condition occurs when a thrombus, most commonly originating from the deep veins of the lower extremities, embolizes to the pulmonary circulation and obstructs blood flow.
Common risk factors include:
- Prolonged immobilization
- Recent surgery
- Malignancy
- Pregnancy and postpartum state
- Previous venous thromboembolism
- Inherited thrombophilia
Clinical presentation can vary widely, ranging from mild dyspnea to sudden hemodynamic collapse.
Key findings may include:
- Acute onset shortness of breath
- Pleuritic chest pain
- Tachycardia
- Hypoxemia
- Syncope in severe cases
One of the most important lessons in clinical medicine is that a normal chest X-ray does not exclude a life-threatening diagnosis.
Diagnostic evaluation often relies on:
- D-dimer testing
- CT Pulmonary Angiography (CTPA)
- Echocardiography in unstable patients
- Clinical prediction tools such as the Wells Score
Early anticoagulation with agents such as:
- Enoxaparin
- Unfractionated Heparin
- Apixaban
- Rivaroxaban
can significantly improve outcomes when initiated promptly.
Pulmonary embolism serves as a reminder that not every patient with acute breathlessness has a primary respiratory disease—sometimes the pathology lies within the pulmonary vasculature itself.”
Stay updated with Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?